Journal article
Selective Serotonin Reuptake Inhibitors (SSRIs) and Markers of Bone Turnover in Men
LJ Williams, M Berk, JM Hodge, MA Kotowicz, AL Stuart, V Chandrasekaran, J Cleminson, JA Pasco
Calcified Tissue International | SPRINGER | Published : 2018
Abstract
Selective serotonin reuptake inhibitors (SSRIs) have been shown to have a clinically significant impact on bone metabolism. To explore this further, we aimed to determine whether these agents are associated with serum markers of bone turnover utilising a population-based sample of men (n = 1138; 20–96 year) participating in the Geelong Osteoporosis Study. Blood samples were obtained and the bone resorption marker, C-telopeptide (CTx) and formation marker, type 1 procollagen amino-terminal-propeptide (PINP) were measured. Anthropometry and socio-economic status (SES) were determined and information on medication use and lifestyle was obtained via questionnaire. Lifetime mood disorders were as..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council (NHMRC), Australia (Projects 299831, 628582, 1009367, 1026265, 1021345, 1104438). LJW is supported by a NHMRC Career Development Fellowship (1064272). MB is supported by a NHMRC Senior Principal Research Fellowship (1059660). VC and JC are supported by Postgraduate Scholarships from Deakin University. The funding providers played no role in the design or conduct of the study; collection, management, analysis and interpretation of the data; or in preparation, review or approval of the manuscript.